• PARIMAL KATOLKAR Department of Pharmaceutical Chemistry, Kamla Nehru College of Pharmacy, Butibori, Nagpur, Maharashtra, India.
  • SHREYA JAISWAL Department of Pharmaceutical Chemistry, Kamla Nehru College of Pharmacy, Butibori, Nagpur, Maharashtra, India.



Method Development, Forced degradation experiments, Method Validation, Cyamemazine tartrate, RP-HPLC, ICH Guidelines


High-performance liquid chromatography (HPLC) technique for cyamemazine tartrate (CYMT) was developed and validated according to the International Conference on Harmonization (ICH) Q2 (R1) guidelines. The developed and validated method for estimating CYMT from a bulk and its pharmaceutical dosage form was found to be a simple, precise, accurate, fast, and stable reverse phase HPLC (RP-HPLC) approach. For chromatographic separation, a Hypersil BDS C18 (250 mm × 4.6 mm, particle size: 5 μm) column was employed with a mobile phase of methanol and buffer (80:20 v/v) flow rate at 1.0 ml/min at room temperature. For detection, a wavelength of 270 nm was utilized. With a run period of 10 min, the CYMT was eluted at 4.38 min. With a correlation coefficient (r2) of above 0.9996, and limits of detection and quantitation (LOD and LOQ) of 0.27 and 0.80 μg, respectively, the method exhibited a dynamic linear response across 30–90 μg/ml. The repeatability of batch injections for intra- and inter-assay precision and accuracy testing was likewise satisfactory. The stability of CYMT was studied under thermal, acid, alkali, and oxidation conditions, as well as photodegradation conditions. The stability of the approach is demonstrated by the presence of CYMT and its breakdown products. The recommended technique exhibited great linearity, accuracy, precision, robustness, LOD, LOQ, and system suitability within the acceptance limit. The study’s findings indicate that the method is rapid, simple, accurate, exact, and linearly stable, implying that an HPLC method for CYMT has been developed and validated, and that it may be used for routine quality control analysis.


Download data is not yet available.


Budavari S, O’Neil MJ, Smith A, Heckelman PE, Kinneary JF. The Merk Index. An Encyclopedia of Chemicals, Drugs and Biologicals. 13th ed. Whitehouse Station, NJ: Merck and Co Inc.; 2001. p. 1097.

Bourin M, Dhonnchadha BA, Colombel MC, Dib M, Hascoët M. Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice. Behav Brain Res 2001;124:87-95. doi: 10.1016/s0166-4328(01)00238-8, PMID 11423169

Ganorkar SB, Kharat SS, Firke SD. ???. Int J Adv Pharm Anal ???;???:???.

Garay RP, d’Alché-Birée F. Cyamémazine: Profil neuroleptique ou anxiolytique? Inf Psychiatr 1995;71:969-71.

Arbus C, Benyamina A, Llorca PM, Baylé F, Bromet N, Massiere F, et al. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine. Eur J Pharm Sci 2007;32:357-66. doi: 10.1016/j.ejps.2007.09.003, PMID 17951033

Da Fonseca BM, Moreno IE, Barroso M, Costa S, Queiroz JA, Gallardo E. Determination of seven selected antipsychotic drugs in human plasma using microextraction in packed sorbent and gas chromatography-tandem mass spectrometry. Anal Bioanal Chem 2013;405:3953-63. doi: 10.1007/s00216-012-6695-y, PMID 23314486

Bévalot F, Bottinelli C, Cartiser N, Fanton L, Guitton J. Quantification of five compounds with heterogeneous physicochemical properties (morphine, 6-monoacetylmorphine, cyamemazine, meprobamate and caffeine) in 11 fluids and tissues, using automated solid-phase extraction and gas chromatography-tandem mass spectrometry. J Anal Toxicol 2014;38:256-64. doi: 10.1093/jat/bku029, PMID 24790060

Bagal D, Nagar A, Joshi A, Chachare A, Shirkhedkar A, Khadse S. Development and validation of stability-indicating RP-HPLC method for estimation of dalfampridine in bulk drug and tablet dosage form. Future J Pharm Sci 2021;7:87.

Kasture AV, Wadodkar SG, Mahadik KR, More HN. Textbook Pharm Anal. 13th ed., Vol. 2. Niraliprakashan: ???; 2005. p. 47-56.

Chatwal GR, Anand SK. Instrumental methods of Chemical Analysis. 11th ed. Mumbai: Himalaya Publishing House; 2005. p. 1.1-2, 2.108-9, 2.151-3.

Deshmukh S, Chavan G, Vanjari S, Patil R. A review on analytical method development and validation by high-performance liquid chromatography technique. J Pharm Sci 2019;11:3599-605.

Prathap B, Dey A, Johnson P, Arthanariswaran P. A review-importance of RP-HPLC in analytical method development. Int J Novel Trends Pharm Sci 2013;3:15-23.

Murugan S, Elayaraja A, Chandrakala K, Ramaiah P, Vulchi C, Babu MN, et al. A review on method development and validation by using HPLC. Int J Novel Trends Pharm Sci 2013;3:78-81.

Lavanya G, Sunil M, Eswarudu MM, Eswaraiah MC, Harisudha K, Spandana BN. Analytical method validation: An updated review. Int J Pharm Sci 2013;4:1280.

Neelam DK, Supriya SM, Nitin SP, Swarup SP, Sajjalavarlakshmi SR. Development and validation of RP-HPLC method for simultaneous estimation of eperisone hydrochloride and diclofenac sodium in bulk and pharmaceutical dosage form. Int J Pharm Chem Biol Sci 2013;3:1286-92.

Branch SK. Guidelines from the international conference on harmonisation (ICH). J Pharm Biomed Anal 2005;38:798-805. doi: 10.1016/j.jpba.2005.02.037, PMID 16076542

Clapham D. Stability Testing. ICH Quality Guidelines. Hoboken, New Jersey: John Wiley and Sons; 2017. p. 45-72.

Ngwa G. Forced degradation as an integral part of HPLC stability-indicating method development. Drug Deliv Technol 2010;10:56-9.

Najana SB, Khandapu BM, Srinivas KS, Bollikolla HB. Quantification of ioversol in injection dosage form using HPLC: Stability indicting method development and validation. Pharm Sci 2019;25:352-7. doi: 10.15171/PS.2019.55

Bakshi M, Singh S. Development of validated stability-indicating assay methods-critical review. J Pharm Biomed Anal 2002;28:1011-40. doi: 10.1016/s0731-7085(02)00047-x, PMID 12049968



How to Cite

KATOLKAR, P., and S. JAISWAL. “ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF CYAMEMAZINE TARTRATE IN FORMULATION BY RP-HPLC WITH STABILITY INDICATING”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 9, Sept. 2022, pp. 28-32, doi:10.22159/ajpcr.2022.v15i9.45154.



Original Article(s)